Ajay Wagh
Pulmonary Disease · Chicago, ILNPI 1851594121
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (49.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Ambu Inc. at 43.5% of the total. Among pulmonary disease clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 287 payments — averaging $225.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ambu Inc.$28K
- Ambu A/s$15K
- Pinnacle Biologics, Inc$5K
- Cook Incorporated$4K
- Noah Medical Corporation$3K
- Pulmonx Corporation$3K
- plus $7K from 31 others
Across 6 payments — averaging $8245.42 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pulmonx Corporation$49K
What the payments were for
- Consulting fees$31,89949%
- Speaking & faculty fees$15,46224%
- Travel & lodging$3,0495%
- Food & beverage$14,25022%
- Education$890%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ambu Inc. | 21 | $28,142 |
| Ambu A/s | 4 | $14,521 |
| Pinnacle Biologics, Inc | 13 | $4,661 |
| Cook Incorporated | 1 | $3,868 |
| Noah Medical Corporation | 67 | $3,492 |
| Pulmonx Corporation | 38 | $2,969 |
| Medtronic | 4 | $1,442 |
| Boston Scientific | 19 | $1,431 |
| Johnson & Johnson | 25 | $1,164 |
| Olympus America Inc. | 9 | $549 |
| Insmed, Inc. | 16 | $344 |
| Covidien LP | 4 | $322 |
| AstraZeneca | 7 | $260 |
| GSK | 13 | $260 |
| Intuitive Surgical | 3 | $225 |
| Olympus Corporation Of The Americas | 2 | $153 |
| Galvanize Therapeutics, Inc | 1 | $136 |
| Boehringer Ingelheim | 7 | $127 |
| Amgen | 1 | $103 |
| Novartis | 5 | $72 |
| Genentech USA, Inc. | 4 | $56 |
| Sunovion Pharmaceuticals Inc. | 5 | $51 |
| Conmed Corporation | 1 | $45 |
| Portola Pharmaceuticals, LLC | 2 | $42 |
| Inogen, Inc. | 2 | $39 |
| Baxter Healthcare | 1 | $38 |
| Steris Corporation | 1 | $38 |
| United Therapeutics Corporation | 2 | $36 |
| Verona Pharma, Inc. | 1 | $24 |
| Mauna Kea Technologies, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Sanofi | 1 | $21 |
| Mallinckrodt Enterprises LLC | 1 | $18 |
| Electromed, Inc. | 1 | $16 |
| Merck | 1 | $14 |
| Philips North America LLC | 1 | $13 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Photofrin$4,426
- Melker$3,868
- GALAXY$2,449
- ILLUMISITE$1,403
- CHARTIS CATHETER$1,291
- PULMONX CHARTIS TABLET CONSOLE$1,291
- ZEPHYR ENDOBRONCHIAL VALVE$1,291
- ZEPHYR DELIVERY CATHETER$1,291
- Pulmonx Endobronchial Valve EBV$1,275
- GENERAL PULMONARY$487
- Monarch Platform$469
- GENERAL - THERAPIES$298
- superDimension$261
- TEZSPIRE$205
- EXALT Model D$144
- SPiN Thoracic Navigation System, 120V, 60Hz$139
- ALIYA SYSTEM$136
- Da Vinci Surgical System$120
- ACQUIRE$110
- FASENRA$102
How this compares
$64,749 in reported general payments places this provider in the 95th percentile of 539 pulmonary disease providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $37,293 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $13,915 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $10,914 |
| Incruse ElliptaUmeclidinium Bromide | 14 | $6,965 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 60 | $2,278 |
| Ventolin HfaAlbuterol Sulfate | 18 | $1,011 |
| Doxycycline Hyclate | 14 | $59 |
| Pantoprazole Sodium | 12 | $35 |
| Prednisone | 11 | $23 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Anoro Ellipta, Incruse Ellipta | $260 | $58,17368 claims |
| AstraZenecaBreztri Aerosphere | $260 | $10,91417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 539 pulmonary disease providers in Illinois.
Other pulmonary disease in Chicago
- Douglas HogarthChicago$2.9M
- Steven WhiteChicago$970K
- Momen WahidiChicago$779K
- Septimiu MurguChicago$633K
- Ayodeji AdegunsoyeChicago$561K
- Ravi KalhanChicago$375K
- Brian GaribaldiChicago$356K
- Manu JainChicago$187K
- Richard WunderinkChicago$178K
- Rade TomicChicago$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.